Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (27)

2022

  1. ICAP-1 loss impairs CD8+ thymocyte development and leads to reduced marginal zone B cells in mice

    European Journal of Immunology, Vol. 52, Núm. 8, pp. 1228-1242

2018

  1. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism

    Annals of the Rheumatic Diseases, Vol. 77, Núm. 5, pp. 752-759

  2. Monocyte-derived dendritic cells differentiated in the presence of lenalidomide display a semi-mature phenotype, enhanced phagocytic capacity, and Th1 polarization capability

    Frontiers in Immunology, Vol. 9, Núm. JUN

2017

  1. Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson's Disease

    ACS Omega, Vol. 2, Núm. 8, pp. 5215-5220

  2. Pharmacological tools based on imidazole scaffold proved the utility of PDE10A inhibitors for Parkinson's disease

    Future Medicinal Chemistry, Vol. 9, Núm. 8, pp. 731-748

  3. Phosphodiesterase7 Inhibition Activates Adult Neurogenesis in Hippocampus and Subventricular Zone In Vitro and In Vivo

    Stem Cells, Vol. 35, Núm. 2, pp. 458-472

  4. Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases

    Journal of Medicinal Chemistry, Vol. 60, Núm. 12, pp. 4983-5001

2016

  1. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins

    Leukemia, Vol. 30, Núm. 4, pp. 861-872

  2. Small GSK-3 Inhibitor shows efficacy in a motor neuron disease murine model modulating autophagy

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Morphometric and neurochemical alterations found in l-BMAA treated rats

    Environmental Toxicology and Pharmacology, Vol. 39, Núm. 3, pp. 1232-1245

  2. PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis

    British Journal of Pharmacology, Vol. 172, Núm. 17, pp. 4277-4290

  3. Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats

    Stem Cells Translational Medicine, Vol. 4, Núm. 6, pp. 564-575

  4. Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice

    Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1160-1173

2014

  1. Modulation of cAMP-specific PDE without emetogenic activity: New sulfide-like PDE7 inhibitors

    Journal of Medicinal Chemistry, Vol. 57, Núm. 20, pp. 8590-8607

2011

  1. CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells

    Journal of Investigative Dermatology, Vol. 131, Núm. 7, pp. 1503-1512

2010

  1. Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: Evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation

    Hepatology, Vol. 51, Núm. 3, pp. 777-787

  2. Mesenchymal stem cells: Biological properties and clinical applications

    Expert Opinion on Biological Therapy, Vol. 10, Núm. 10, pp. 1453-1468

  3. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 298, Núm. 3

2009

  1. Glucokinase and glucokinase regulatory proteins are functionally coexpressed before birth in the rat brain

    Journal of Neuroendocrinology, Vol. 21, Núm. 12, pp. 973-981

  2. Identification of genes responsive to solar simulated UV radiation in human monocyte-derived dendritic cells

    PLoS ONE, Vol. 4, Núm. 8